Technology platforms
Your partner for rapid, reliable antibody discovery and high-quality bioproduction.
InVivo BioTech Services accelerates your path from concept to high‑performance biologics. We collaborate with certified external animal facilities (rabbits and mice), and drive antibody development using both an optofluidic Beacon® platform and classical hybridoma workflows.
InVivo enables rapid, high‑resolution antibody screening through the Beacon® platform, giving you direct access to true single‑cell analysis. Our team uses this technology to observe secretion, binding, and functional performance from individual B‑cells in real time, allowing you to identify top‑performing clones with exceptional precision. By integrating Beacon‑based functional assays into your workflow, InVivo accelerates discovery timelines and ensures that only the most promising antibody candidates advance. Benefits for our customers: Lengthy hybridoma timelines — or delayed project phases caused by traditional hybridoma or phage display approaches — are rapidly surpassed by our accelerated, high‑resolution antibody discovery workflow.
Beacon® platform
Our team isolates candidate B‑cells, performs rapid functional screening directly on the Beacon® platform, and can provide exportable cell lines for your downstream programs.
Advantages:
- Access to the superior rabbit immune repertoire with high‑affinity, high‑specificity antibodies
- True single‑cell resolution through optofluidic Beacon® technology
- Real‑time functional screening of individual B‑cells (binding, secretion, activity)
- Dramatically shortened discovery timelines compared to hybridoma or phage display
- Ability to identify rare, high‑value clones that traditional methods often miss
- Direct linkage of phenotype and genotype at the single‑cell level
- Exportable cells for seamless integration into external pipelines
- Ideal for challenging antigens, low‑immunogenic targets, and complex epitopes
Bioproduction platform
With decades of experience in large‑scale bioproduction, we deliver recombinant proteins, antibodies, and monoclonal antibodies at consistently high quality. Our production platforms include CHO and HEK expression systems as well as robust E. coli processes, supported by scalable bioreactor capacities.
Advantages:
- Quick adaption from small-scale to large-scale antibody production
- Serum-free production, free of endotoxins & aggregates
- Upscaling possible from 2 – 100 L cultivations
- High reproducibility
- Antibody yield up to 1 kg
Analytical platforms
To ensure scientific rigor and product excellence, we offer a comprehensive suite of in‑house biophysical and analytical methods, including SPR affinity analysis, MALDI‑TOF mass spectrometry, ELISA, size‑exclusion chromatography, and the development of custom immunoassays tailored to your project.
SPR- 32 Pro:
- High-throughput molecular interaction analysis
- Real-time, label-free binding studies
- Kinetic & affinity characterization
- Small molecule & fragment screening
- Epitope binning & antibody characterization
MALDI Biotyper:
- Rapid mass analysis of biomolecules
- Fast QC checks for peptide fragments
- Ultra-fast microbial identification
- Broad application range with advanced technology
- High accuracy
You are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information